October 31, 2012
Takeda Pharmaceutical announced on October 30 that it has filed a new drug application (NDA) to the Ministry of Health, Labor and Welfare (MHLW) for cetilistat (development code: ATL-962) for the treatment of obesity with its complications. The company has...read more